|
|
|
|
LEADER |
01602nam a2200229 u 4500 |
001 |
EB002010705 |
003 |
EBX01000000000000001173604 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
220201 r ||| eng |
100 |
1 |
|
|a Brett, Kendra
|
245 |
0 |
0 |
|a Interventions for temporomandibular joint disorder
|h Elektronische Ressource
|b an overview of systematic reviews
|c Kendra Brett [and 5 others]
|
260 |
|
|
|a Ottawa (ON)
|b Canadian Agency for Drugs and Technologies in Health
|c September 28, 2018, 2018
|
300 |
|
|
|a 1 PDF file (108 pages)
|b illustrations
|
505 |
0 |
|
|a Includes bibliographical references
|
710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a CADTH rapid response report: systematic review
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK544538
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a Temporomandibular disorders (TMD) are disorders involving the temporomandibular joint (TMJ) and associated structures, and affect 5% to 12% of individuals. TMD can lead to chronic pain, tooth grinding, and cervical spine and mobility issues, all of which are precursors to more serious impairment of function. There are a plethora of different strategies to treat TMD, including pharmacological interventions, non-surgical interventions, and surgery. This overview of reviews aims to summarize evidence regarding the clinical effectiveness and safety of interventions in adults (17 and older) and children (0 to 17) with TMD.
|